Jeffrey Botbyl

1.4k total citations
28 papers, 1.0k citations indexed

About

Jeffrey Botbyl is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeffrey Botbyl has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeffrey Botbyl's work include Cutaneous Melanoma Detection and Management (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Computational Drug Discovery Methods (3 papers). Jeffrey Botbyl is often cited by papers focused on Cutaneous Melanoma Detection and Management (8 papers), Colorectal Cancer Treatments and Studies (4 papers) and Computational Drug Discovery Methods (3 papers). Jeffrey Botbyl collaborates with scholars based in United States, United Kingdom and Netherlands. Jeffrey Botbyl's co-authors include Phyllis A. Gimotty, DuPont Guerry, Brian J. Czerniecki, Francis R. Spitz, Michael E. Ming, Douglas L. Fraker, David E. Elder, Ronald J. Buckanovich, Lance A. Liotta and George Coukos and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Gastroenterology and Hepatology.

In The Last Decade

Jeffrey Botbyl

25 papers receiving 980 citations

Peers

Jeffrey Botbyl
Victoria Mar Australia
Euphemia W. Mu United States
Andrea Forschner Germany
Kelly Huynh United States
Maeve Mullooly Ireland
Nagarajan Kannan United States
Brian M. Nolen United States
Werner Rittgen Germany
Dennis L. Rousseau United States
Dejun Shen United States
Victoria Mar Australia
Jeffrey Botbyl
Citations per year, relative to Jeffrey Botbyl Jeffrey Botbyl (= 1×) peers Victoria Mar

Countries citing papers authored by Jeffrey Botbyl

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Botbyl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Botbyl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Botbyl more than expected).

Fields of papers citing papers by Jeffrey Botbyl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Botbyl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Botbyl. The network helps show where Jeffrey Botbyl may publish in the future.

Co-authorship network of co-authors of Jeffrey Botbyl

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Botbyl. A scholar is included among the top collaborators of Jeffrey Botbyl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Botbyl. Jeffrey Botbyl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ramdas, Kevin, Joshua M. Hare, Jeffrey L. Cummings, et al.. (2024). Results from a Phase 2a Proof‐of‐Concept Double‐Blind, Randomized, Placebo‐Controlled Trial of Lomecel‐BTM in Mild Alzheimer’s Disease Dementia. Alzheimer s & Dementia. 20(S6). 1 indexed citations
3.
Batterham, Philip J., Frances P. Thorndike, Robert Gerwien, et al.. (2023). Sleep-specific outcomes attributable to digitally delivered cognitive behavioral therapy for insomnia in adults with insomnia and depressive symptoms. Behavioral Sleep Medicine. 22(4). 410–419. 1 indexed citations
4.
Berry, Sameer, et al.. (2023). A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. 21(12). 3152–3159.e2. 18 indexed citations
5.
6.
7.
Koch, Kevin M., Young‐Hyuck Im, Sung‐Bae Kim, et al.. (2013). Effects of Esomeprazole on the Pharmacokinetics of Lapatinib in Breast Cancer Patients. Clinical Pharmacology in Drug Development. 2(4). 336–341. 23 indexed citations
8.
Brady, Joanne E., Pippa Corrie, Ian Chau, et al.. (2013). An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer. Investigational New Drugs. 31(5). 1228–1235. 9 indexed citations
9.
Minthorn, Elisabeth A., Stanley W. Carson, Graeme Young, et al.. (2013). Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation‐Positive Solid Tumors. The Journal of Clinical Pharmacology. 53(9). 955–961. 30 indexed citations
10.
Tan, Antoinette R., Darlene Gibbon, Mark N. Stein, et al.. (2013). Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 71(6). 1635–1643. 90 indexed citations
11.
Plummer, Ruth, Ayman Madi, Heike Richly, et al.. (2012). A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(1). 93–101. 25 indexed citations
12.
Chung, Vincent, Elisabeth I. Heath, William R. Schelman, et al.. (2011). First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. Cancer Chemotherapy and Pharmacology. 69(3). 733–741. 66 indexed citations
13.
Holen, Kyle D., E. Heath, William R. Schelman, et al.. (2010). Phase I first-in-human study of the centromere-associated protein E (CENP-E) inhibitor GSK923295 in patients with advanced solid tumors (study CPE107602).. Journal of Clinical Oncology. 28(15_suppl). 3012–3012. 2 indexed citations
14.
Gimotty, Phyllis A., David E. Elder, Douglas L. Fraker, et al.. (2007). Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas. Journal of Clinical Oncology. 25(9). 1129–1134. 135 indexed citations
15.
Buckanovich, Ronald J., Dimitra Sasaroli, Ann O’Brien-Jenkins, et al.. (2006). Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment. Cancer Biology & Therapy. 5(6). 635–642. 48 indexed citations
16.
Bleier, Benjamin S., Virginia A. LiVolsi, Ara A. Chalian, et al.. (2006). Technetium Tc 99m Sestamibi Sensitivity in Oxyphil Cell–Dominant Parathyroid Adenomas. Archives of Otolaryngology - Head and Neck Surgery. 132(7). 779–779. 26 indexed citations
17.
Karakousis, Giorgos C., Phyllis A. Gimotty, Jeffrey Botbyl, et al.. (2006). Predictors of Regional Nodal Disease in Patients With Thin Melanomas. Annals of Surgical Oncology. 13(4). 533–541. 74 indexed citations
18.
Kesmodel, Susan B., Giorgos C. Karakousis, Jeffrey Botbyl, et al.. (2005). Mitotic Rate as a Predictor of Sentinel Lymph NodePositivity in Patients With Thin Melanomas. Annals of Surgical Oncology. 12(6). 449–458. 167 indexed citations
19.
Kruper, Laura, Jeffrey Botbyl, D Elder, et al.. (2005). Predicting sentinel lymph node status in stage I/II melanoma. Journal of Clinical Oncology. 23(16_suppl). 7501–7501. 9 indexed citations
20.
Guerry, DuPont, Jeffrey Botbyl, & Phyllis A. Gimotty. (2004). A population-based validation of the AJCC melanoma staging system. Journal of Clinical Oncology. 22(14_suppl). 7500–7500. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Mar Breakdown of academic impact, for papers by Euphemia W. Mu Breakdown of academic impact, for papers by Andrea Forschner Breakdown of academic impact, for papers by Kelly Huynh Breakdown of academic impact, for papers by Maeve Mullooly Breakdown of academic impact, for papers by Nagarajan Kannan Breakdown of academic impact, for papers by Brian M. Nolen Breakdown of academic impact, for papers by Werner Rittgen Breakdown of academic impact, for papers by Dennis L. Rousseau Breakdown of academic impact, for papers by Dejun Shen
Rankless by CCL
2026